Cambridge Clinical Laboratories Acquired by Source BioScience
Source BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
Source BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Xifin has added two major payors to its Payor Rate Transparency Monitor. Labs will now have even more data to help with reimbursements.
COLA appointed Lynn Jeffers to its board of directors, bringing her extensive leadership experience in healthcare to support COLA.
The FDA’s new LDT rule could severely limit access to vital diagnostics, particularly in rural and marginalized communities, ADLM says.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Join us for a deep dive into Anti-Xa assay testing for heparin and DOACs. This expert-led webinar explores clinical applications, lab best practices, and assay standardization. Ideal for lab professionals, clinicians, and pharmacists aiming to optimize anticoagulation therapy and improve patient outcomes. Register now for this valuable session on April 29th, 2025.